Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

NCT07325214 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer
Borderline Resectable Pancreatic Cancer
Locally Advanced Pancreatic Cancer

Interventions

DEVICE: IMD10
DRUG: chemotherapy regimen [irinotecan hydrochloride, oxaliplatin, fluorouracil (5-FU) and leucovorin]

Sponsor

IMGT Co., Ltd.